All Pharma News
BIOVECTRA Partners To Establish Domestic Immunotherapy Supply Chain

BIOVECTRA Partners To Establish Domestic Immunotherapy Supply Chain
PRESS RELEASE
26 Feb 2024
Share Share
CDMO Biovectra boosts Canada mRNA capabilities

CDMO Biovectra boosts Canada mRNA capabilities
BIOPROCESS INTERNATIONAL
27 Nov 2023
Share Share
BIOVECTRA Launches Specialized Capabilities in mRNA Drug Product Development

BIOVECTRA Launches Specialized Capabilities in mRNA Drug Product Development
BUSINESSWIRE
17 Nov 2023
Share Share
BIOVECTRA Signs Service Agreement With Acuitas Therapeutics

BIOVECTRA Signs Service Agreement With Acuitas Therapeutics
BUSINESSWIRE
05 Oct 2023
Share Share
BIOVECTRA Starts Construction on its Charlottetown mRNA Biomanufacturing Centre

BIOVECTRA Starts Construction on its Charlottetown mRNA Biomanufacturing Centre
BUSINESSWIRE
14 Apr 2022
Share Share
BIOVECTRA mRNA Vaccine and Bio-Manufacturing Facility Announced

BIOVECTRA mRNA Vaccine and Bio-Manufacturing Facility Announced
BUSINESSWIRE
18 Nov 2021
Share Share
BIOVECTRA Appoints Steven M. Klosk, Gordon C. Mccauley to Board

BIOVECTRA Appoints Steven M. Klosk, Gordon C. Mccauley to Board
BUSINESSWIRE
21 Oct 2021
Share Share
Biovectra Enhances Manufacturing Capacity and Flexibility with ABEC’s Technology

Biovectra Enhances Manufacturing Capacity and Flexibility with ABEC’s Technology
BIOSPACE
20 Sep 2021
Share Share
Mallinckrodt agrees to sell CDMO business for $250m

Mallinckrodt agrees to sell CDMO business for $250m
IN-PHARMATECHNOLOGIST
12 Sep 2019
Share Share
Mallinckrodt Agrees to Sell BioVectra Inc. to H.I.G. Capital for $250 Million

Mallinckrodt Agrees to Sell BioVectra Inc. to H.I.G. Capital for $250 Million
BIOSPACE
11 Sep 2019
Share Share